Document is current
Any future updates will be listed below
-
Authors
Belmont-Rausch, Dylan M. https://orcid.org/0000-0001-6095-4891
Ludwig, Mette Q. https://orcid.org/0000-0002-7814-3859
Bentsen, Marie A.
Hansen, Stine N.
Secher, Anna https://orcid.org/0000-0002-6276-5389
Holst, Dorte
Moreno, Jaime https://orcid.org/0009-0006-6173-8879
Das, Vivek https://orcid.org/0000-0003-0614-0373
Egerod, Kristoffer L. https://orcid.org/0000-0003-2781-1594
Bjerregaard, Anne-Mette https://orcid.org/0000-0002-1831-6746
Niss, Kristoffer
Bau, Sarah https://orcid.org/0000-0002-2873-7974
Pyke, Charles
Dalgaard, Kevin
Merkestein, Myrte
Wichern, Franziska
Hansen, Charlotte Thim
Polex-Wolf, Joseph
Knudsen, Lotte Bjerre https://orcid.org/0000-0002-2439-7116
Pers, Tune H. https://orcid.org/0000-0003-0207-4831
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18CC0034900)
Lundbeckfonden (R190-2014-3904)
Det Frie Forskningsråd (8045-00091B)
Foundation for the National Institutes of Health (R01 DK124238)
- License Information
-
More Information
Article History
Received: 25 April 2025
Accepted: 27 May 2026
First Online: 9 June 2026
Competing interests
: THP receives research support from the Novo Nordisk A/S, his household holds stocks in Novo Nordisk A/S and he has received counseling fees from Eli Lilly and Zealand Pharma. During completion of this study, DMR, MAB and MQL have become employed at Novo Nordisk A/S; K.D. has become employed at the Lundbeck Foundation; and F.W. at Lundbeck A/S. S.N.H., A.S., D.H., J.M., V.D., A.M.B., K.N., S.B., C.P., M.M., C.T.H., J.P.W., L.B.K. are employees at Novo Nordisk A/S. All other authors have no competing interests to declare.
: During the preparation of this work the authors used generative AI tools to improve readability and language of the manuscript. After using these services, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.
